Here comes a few words from Linnea and David, two members of
the ISBgroup in Linkoping.

We are both currently living in Boston, USA,
experiencing systems biology in an industrial environment.

We are doing internships as modelers at Merrimack
Pharmaceuticals, a biopharmaceutical company focused on cancer drug development
using network biology. Linnea’s project involves mechanistic modeling of the
DNA damage response pathway, aiming at identifying possible synergistic drug
combinations. David’s project concerns PKPD-modeling of an in-house drug which
currently is in the end of its pre-clinical phase.

One month into our
internships, we have experienced long and intense work days, learned about the
company and its pipeline, lasted through a “monster blizzard”, and met a lot of
talented people from all over the world.

Linnea Bergenholm and David Janzen at Merrimack
Pharmaceuticals, Boston.